Mono Pharmacare Ltd.
•₹ 8.450.6%
2026-08-21
PROS
- Company converts assets efficiently - asset turnover of 1.8x
CONS
- Company has a high debt-to-equity of 1.72x
- Operating cash flow has been negative in recent years
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -6.52x)
- Company has a low return on capital employed of 8.1%
- Company has a low return on equity of 9.2% over last 3 years
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | ADANIENT | 2979.00 | 54.17 | 403273.96 | 0.04 | -1461.54 | -249.67 | 32923.98 | 49.92 | 13.30 | 15.57 |
| 2. | AEGISLOG | 1363.65 | 38.25 | 47864.12 | 0.64 | 544.84 | 210.70 | 2356.86 | 37.07 | 19.76 | 30.28 |
| 3. | PREMIERENE | 1008.00 | 27.48 | 45758.31 | 0.10 | 471.92 | 53.32 | 2462.59 | 35.25 | 41.97 | 29.03 |
| 4. | CPPLUS | 3307.45 | 81.98 | 39127.28 | 0.05 | 142.20 | 332.51 | 1402.42 | 89.51 | 29.48 | 14.52 |
| 5. | REDINGTON | 334.90 | 15.39 | 26181.63 | 1.79 | 453.49 | 94.65 | 34922.47 | 34.57 | 18.96 | 2.03 |
| 6. | HONASA | 476.90 | 62.48 | 15548.09 | 0.63 | 90.45 | 118.87 | 755.95 | 27.00 | 8.99 | 14.58 |
| 7. | LLOYDSENT | 78.59 | 106.84 | 11997.17 | 0.19 | 109.98 | -55.77 | 563.03 | 70.15 | 12.84 | 18.07 |
| 8. | SGMART | 805.80 | 81.69 | 10155.92 | 0.00 | 455.80 | 1310.71 | 13085.70 | 1044.08 | 11.45 | 4.49 |
| 9. | MMTC | 62.10 | 20.82 | 9315.00 | 0.00 | 104.24 | 135.52 | 0.68 | -50.00 | 6.90 | -1423.53 |
| 10. | CELLO | 358.45 | 25.31 | 7917.62 | 0.42 | 73.40 | -8.99 | 526.72 | -0.43 | 17.15 | 18.80 |
| 11. | EBGNG | 588.80 | 47.13 | 6713.00 | 0.00 | 289.30 | 1462.10 | 4124.61 | 1220.81 | 20.14 | 11.97 |
| 12. | MONOPHARMA | 8.20 | 41.04 | 14.49 | 0.00 | — | — | — | — | 11.00 | — |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
No quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 27 | 122 | 168 | |
| 25 | 116 | 161 | |
| Operating Profit | 2 | 6 | 9 |
| OPM % | 6 | 5 | 5 |
| Other Income | 0 | 0 | 1 |
| Interest | 1 | 3 | 4 |
| Depreciation | 0 | 0 | 0 |
| 1 | 3 | 4 | |
| Tax % | 25 | 24 | 30 |
| Net Profit | 1 | 2 | 3 |
| EPS | 1 | 1 | 2 |
| Dividend Payout % | 0 | 0 | 0 |
| Minority Interest | -0 | -0 | -0 |
| Share of Associates | 0 | 0 | 0 |
| Adjusted EPS | 1 | 1 | 2 |
| Minority Interest | -0 | -0 | -0 |
| Share of Associates | 0 | 0 | 0 |
| Adjusted EPS | 1 | 1 | 2 |
Mar 2023
- 27
- 25
- Operating Profit
- 2
- OPM %
- 6
- Other Income
- 0
- Interest
- 1
- Depreciation
- 0
- 1
- Tax %
- 25
- Net Profit
- 1
- EPS
- 1
- Dividend Payout %
- 0
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2024
- 122
- 116
- Operating Profit
- 6
- OPM %
- 5
- Other Income
- 0
- Interest
- 3
- Depreciation
- 0
- 3
- Tax %
- 24
- Net Profit
- 2
- EPS
- 1
- Dividend Payout %
- 0
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2025
- 168
- 161
- Operating Profit
- 9
- OPM %
- 5
- Other Income
- 1
- Interest
- 4
- Depreciation
- 0
- 4
- Tax %
- 30
- Net Profit
- 3
- EPS
- 2
- Dividend Payout %
- 0
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- 2
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- 2
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- -66%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 9%
- Last Year:
- 10%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| LIABILITIES | - | - | - |
| Equity Capital | 12 | 18 | 18 |
| 1 | 10 | 14 | |
| 22 | 24 | 28 | |
| Trade Payables | 7 | 10 | 19 |
| 20 | 19 | 32 | |
| Total Liabilities | 63 | 81 | 110 |
| ASSETS | - | - | - |
| 1 | 1 | 1 | |
| 1 | 0 | 0 | |
| 33 | 42 | 55 | |
| 0 | 32 | 42 | |
| Cash & Bank | 0 | 0 | 1 |
| 28 | 6 | 11 | |
| Total Assets | 63 | 81 | 110 |
| Total Debt | 40 | 41 | 54 |
| Net Working Capital | 30 | 44 | 56 |
| Contingent Liabilities | 0 | 0 | 0 |
| Book Value per Share | 10.82 | 15.91 | 17.66 |
| Face Value | 10.00 | 10.00 | 10.00 |
| Total Debt | 40 | 41 | 54 |
| Net Working Capital | 30 | 44 | 56 |
| Contingent Liabilities | 0 | 0 | 0 |
| Book Value per Share | 10.82 | 15.91 | 17.66 |
| Face Value | 10.00 | 10.00 | 10.00 |
Mar 2023
- Equity Capital
- 12
- 1
- 22
- Trade Payables
- 7
- 20
- Total Liabilities
- 63
- 1
- 1
- 33
- 0
- Cash & Bank
- 0
- 28
- Total Assets
- 63
- Total Debt
- 40
- Net Working Capital
- 30
- Contingent Liabilities
- 0
- Book Value per Share
- 10.82
- Face Value
- 10.00
- Total Debt
- 40
- Net Working Capital
- 30
- Contingent Liabilities
- 0
- Book Value per Share
- 10.82
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 18
- 10
- 24
- Trade Payables
- 10
- 19
- Total Liabilities
- 81
- 1
- 0
- 42
- 32
- Cash & Bank
- 0
- 6
- Total Assets
- 81
- Total Debt
- 41
- Net Working Capital
- 44
- Contingent Liabilities
- 0
- Book Value per Share
- 15.91
- Face Value
- 10.00
- Total Debt
- 41
- Net Working Capital
- 44
- Contingent Liabilities
- 0
- Book Value per Share
- 15.91
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 18
- 14
- 28
- Trade Payables
- 19
- 32
- Total Liabilities
- 110
- 1
- 0
- 55
- 42
- Cash & Bank
- 1
- 11
- Total Assets
- 110
- Total Debt
- 54
- Net Working Capital
- 56
- Contingent Liabilities
- 0
- Book Value per Share
- 17.66
- Face Value
- 10.00
- Total Debt
- 54
- Net Working Capital
- 56
- Contingent Liabilities
- 0
- Book Value per Share
- 17.66
- Face Value
- 10.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| -28 | -9 | -4 | |
| Cash from Investing | -1 | 0 | -0 |
| Cash from Financing | 30 | 8 | 5 |
| 0 | -0 | 0 | |
| Free Cash Flow | -28 | -9 | -5 |
| OCF / Net Profit | -39.56 | -3.57 | -1.39 |
| Cumulative 5-Year FCF | 0 | 0 | 0 |
| OCF / Net Profit | -39.56 | -3.57 | -1.39 |
| Cumulative 5-Year FCF | 0 | 0 | 0 |
Mar 2023
- -28
- Cash from Investing
- -1
- Cash from Financing
- 30
- 0
- Free Cash Flow
- -28
- OCF / Net Profit
- -39.56
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -39.56
- Cumulative 5-Year FCF
- 0
Mar 2024
- -9
- Cash from Investing
- 0
- Cash from Financing
- 8
- -0
- Free Cash Flow
- -9
- OCF / Net Profit
- -3.57
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -3.57
- Cumulative 5-Year FCF
- 0
Mar 2025
- -4
- Cash from Investing
- -0
- Cash from Financing
- 5
- 0
- Free Cash Flow
- -5
- OCF / Net Profit
- -1.39
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -1.39
- Cumulative 5-Year FCF
- 0
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| PER SHARE | - | - | - |
| EPS (₹) | 0.57 | 1.38 | 1.75 |
| Book Value (₹) | 10.82 | 15.91 | 17.66 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 0.61 | 1.46 | 1.83 |
| PROFITABILITY | - | - | - |
| Operating Margin % | 6.48% | 5.17% | 4.54% |
| Net Margin % | 2.60% | 2.01% | 1.84% |
| ROE % | 5.24% | 11.85% | 10.47% |
| ROCE % | 3.16% | 10.22% | 11.00% |
| 1.12% | 3.42% | 3.25% | |
| EFFICIENCY | - | - | - |
| Debtor Days | 296 | 80 | 80 |
| Inventory Days | 442 | 112 | 106 |
| Payable Days | 103 | 27 | 34 |
| 635 | 164 | 151 | |
| FINANCIAL HEALTH | - | - | - |
| Debt to Equity (x) | 3.03x | 1.47x | 1.72x |
| Interest Coverage (x) | 2.21x | 2.05x | 2.11x |
| 1.96x | 2.24x | 2.07x | |
| GROWTH | - | - | - |
| Revenue Growth % | 0.00% | 353.27% | 37.60% |
| Operating Profit Growth % | 0.00% | 267.51% | 34.14% |
| Net Profit Growth % | 0.00% | 250.51% | 26.32% |
| 0.00% | 144.35% | 26.53% | |
| VALUATION | - | - | - |
| P/E (x) | 0.00x | 31.90x | 13.21x |
| P/B (x) | 0.00x | 2.77x | 1.31x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% |
| 0.00x | 18.52x | 10.87x |
Mar 2023
- EPS (₹)
- 0.57
- Book Value (₹)
- 10.82
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.61
- Operating Margin %
- 6.48%
- Net Margin %
- 2.60%
- ROE %
- 5.24%
- ROCE %
- 3.16%
- 1.12%
- Debtor Days
- 296
- Inventory Days
- 442
- Payable Days
- 103
- 635
- Debt to Equity (x)
- 3.03x
- Interest Coverage (x)
- 2.21x
- 1.96x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 1.38
- Book Value (₹)
- 15.91
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 1.46
- Operating Margin %
- 5.17%
- Net Margin %
- 2.01%
- ROE %
- 11.85%
- ROCE %
- 10.22%
- 3.42%
- Debtor Days
- 80
- Inventory Days
- 112
- Payable Days
- 27
- 164
- Debt to Equity (x)
- 1.47x
- Interest Coverage (x)
- 2.05x
- 2.24x
- Revenue Growth %
- 353.27%
- Operating Profit Growth %
- 267.51%
- Net Profit Growth %
- 250.51%
- 144.35%
- P/E (x)
- 31.90x
- P/B (x)
- 2.77x
- Dividend Yield %
- 0.00%
- 18.52x
Mar 2025
- EPS (₹)
- 1.75
- Book Value (₹)
- 17.66
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 1.83
- Operating Margin %
- 4.54%
- Net Margin %
- 1.84%
- ROE %
- 10.47%
- ROCE %
- 11.00%
- 3.25%
- Debtor Days
- 80
- Inventory Days
- 106
- Payable Days
- 34
- 151
- Debt to Equity (x)
- 1.72x
- Interest Coverage (x)
- 2.11x
- 2.07x
- Revenue Growth %
- 37.60%
- Operating Profit Growth %
- 34.14%
- Net Profit Growth %
- 26.32%
- 26.53%
- P/E (x)
- 13.21x
- P/B (x)
- 1.31x
- Dividend Yield %
- 0.00%
- 10.87x
Documents
Announcements
Nothing filed yet.
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Nothing filed yet.